Intelligence ยท Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors โ phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text โ searchable for business development and competitive intelligence.
-
Trandolapril 4 mg Tablets
Teva Pharma GmbH
Healthy
2 trials -
Treatment A: Fp MDPI
Teva Pharma GmbH
Asthma
1 trial -
Ursodiol
Teva Pharma GmbH
Healthy
2 trials -
Valacyclovir
Teva Pharma GmbH
Healthy
2 trials -
Venlafaxine 25 mg Tablets
Teva Pharma GmbH
Healthy
2 trials -
Venlafaxine Hydrochloride
Teva Pharma GmbH
Healthy
3 trials -
XM17
Teva Pharma GmbH
Bioequivalence
1 trial -
Zaleplon 10 mg Capsules
Teva Pharma GmbH
Healthy
2 trials -
Zithromaxยฎ
Teva Pharma GmbH
Healthy
1 trial -
Zoloftยฎ 100 mg Tablets
Teva Pharma GmbH
Healthy
2 trials -
Zolpidem 10 mg tablets
Teva Pharma GmbH
Healthy
2 trials -
a 60 mg dose of the hydrocodone bitartrate extended-release tablet administered as either two 30-mg tablets (Treatment A) or one 60-mg tablet (Treatment B).
Teva Pharma GmbH
Pain
1 trial -
amoxicillin-clavulanic acid
Teva Pharma GmbH
Healthy
2 trials -
anle138b (TEV-56286)
Teva Pharma GmbH
Healthy Volunteers
1 trial -
bendamustine
Teva Pharma GmbH
Malignancy
1 trial -
cefprozil
Teva Pharma GmbH
Healthy
1 trial -
hGH-ViaDermโข System (hGH or somatropin)
Teva Pharma GmbH
Growth Hormone Deficiency
1 trial -
laquinimod
Teva Pharma GmbH
Pharmacokinetics
1 trial -
lipegfilgrastim
Teva Pharma GmbH
Pharmacokinetics
1 trial -
medroxyprogesterone acetate
Teva Pharma GmbH
Healthy
1 trial -
omacetaxine mepesuccinate
Teva Pharma GmbH
Hematologic Malignancies
1 trial -
pravastatin
Teva Pharma GmbH
Healthy
2 trials -
pravastatin sodium
Teva Pharma GmbH
Healthy
1 trial -
16 mg buprenorphine with 4 mg naloxone sublingual film
Teva Pharma GmbH
Evaluation of QTc Interval
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1โ3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync โ verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources